GO:0004810 CCA tRNA nucleotidyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004810 describes the enzymatic activity that adds the 3' CCA trinucleotide to tRNA precursors, a universally conserved step required for tRNA maturation and aminoacylation.
• The reaction uses ATP and CTP as substrates and releases pyrophosphate, producing a mature tRNA with a 3' CCA end.
• The enzyme is encoded by the cca gene in bacteria and by TRNT1 in humans; bacterial CCA-adding enzyme is not essential for viability under standard laboratory conditions, but loss of human TRNT1 causes disease.
• CCA addition occurs without translocation of the tRNA substrate, a unique polymerization mechanism.
• The activity is not limited to tRNA: the same enzyme can add CCA to U2 small nuclear RNA, linking it to broader RNA processing.
• Disease-linked variants of human TRNT1 show decreased thermal stability and altered catalytic activity, providing a direct genotype-phenotype link.
Description
CCA tRNA nucleotidyltransferase activity (GO:0004810) is a molecular function that ensures every tRNA molecule carries the invariant 3' CCA sequence required for amino acid attachment. This activity was first described as a tRNA nucleotidyltransferase and is now known to be encoded by the cca gene in bacteria and by TRNT1 in humans. The enzyme catalyzes the addition of two CTP and one ATP to the 3' end of tRNA precursors, releasing pyrophosphate and generating the mature 3' CCA terminus. Because aminoacyl-tRNA synthetases recognize the 3' CCA end, this activity is a prerequisite for protein synthesis. Researchers study GO:0004810 to understand tRNA maturation, RNA quality control, and the molecular basis of diseases linked to TRNT1 dysfunction. The activity is also a target of bacterial toxin-antitoxin systems, where a nucleotidyltransferase toxin modifies tRNA acceptor ends to control growth.
CCA tRNA nucleotidyltransferase activity At A Glance
| GO ID | GO:0004810 |
|---|---|
| GO term | CCA tRNA nucleotidyltransferase activity |
| Ontology | molecular_function |
| Synonym | CCA-adding enzyme activity; tRNA nucleotidyltransferase; ATP(CTP):tRNA nucleotidyltransferase; CTP(ATP):tRNA nucleotidyltransferase; transfer RNA adenylyltransferase |
| Major function | Adds the 3' CCA trinucleotide to tRNA precursors using ATP and CTP, generating mature tRNA ends required for aminoacylation |
| Reaction | tRNA precursor + ATP + 2 CTP = tRNA with 3' CCA end + 3 diphosphate |
| Substrates | tRNA precursor, ATP, CTP |
| Products | tRNA with 3' CCA end, diphosphate |
| Cellular location | Cytoplasm and mitochondria (for human TRNT1); cytoplasm for bacterial CCA-adding enzyme |
| Representative genes | cca (E. coli), cca (B. subtilis), TRNT1 (human) |
What Is GO:0004810?
According to the Gene Ontology, GO:0004810 is defined as the catalysis of the reaction: a tRNA precursor + ATP + 2 CTP = a tRNA with a 3' CCA end + 3 diphosphate. In other words, the enzyme uses ATP and CTP to add the trinucleotide CCA to the 3' end of a tRNA molecule that lacks it, releasing pyrophosphate. This activity is also known as CCA-adding enzyme activity, tRNA nucleotidyltransferase, or ATP(CTP):tRNA nucleotidyltransferase.
Why Is CCA tRNA nucleotidyltransferase activity Important in Cell Biology?
GO:0004810 is essential because the 3' CCA sequence is the universal amino acid attachment site of all tRNAs. Without this activity, tRNA precursors cannot be aminoacylated, and protein synthesis stalls. The enzyme is conserved from bacteria to humans, and its mechanism has been studied for decades as a model of template-independent RNA polymerization. In humans, mutations in TRNT1 cause a rare multisystem disease with retinitis pigmentosa, immunodeficiency, and developmental delay, making the enzyme a direct link between a basic RNA modification and human pathology. In bacteria, toxin-antitoxin systems can hijack this activity to modify tRNA and control growth, highlighting its role in stress responses and persistence. The enzyme also acts on U2 snRNA, expanding its functional repertoire beyond tRNA.
• Required for tRNA maturation and aminoacylation, making it indispensable for translation.
• Mutations in human TRNT1 cause a disease spectrum including retinitis pigmentosa, immunodeficiency, and developmental delay.
• Bacterial CCA-adding enzyme is a model for template-independent RNA polymerization and enzyme mechanism.
• The activity is targeted by bacterial toxin MenT, linking it to growth control and persistence in Mycobacterium tuberculosis.
• CCA addition to U2 snRNA suggests roles in spliceosomal RNA processing.
• The enzyme is not essential for E. coli viability under standard conditions, making it a useful model for studying redundancy and stress responses.
• Disease-linked TRNT1 variants show altered thermal stability and catalytic activity, providing a platform for genotype-phenotype studies.
• The activity is a potential target for antibacterial strategies that disrupt tRNA maturation.
What Happens During CCA tRNA nucleotidyltransferase activity?
Substrate recognition and binding
In simple terms: The enzyme first grabs the tRNA molecule that needs its CCA tail.
The CCA-adding enzyme recognizes the 3' end of tRNA precursors that lack the CCA sequence. It binds the tRNA acceptor stem and positions the 3' terminus in the active site. This binding is template-independent and relies on structural features of the tRNA rather than a nucleic acid template.
Polymerization without translocation
In simple terms: The enzyme adds the three nucleotides one by one without moving along the tRNA.
Unlike typical polymerases, the CCA-adding enzyme adds CTP, CTP, and ATP sequentially without translocating along the tRNA substrate. The enzyme active site rearranges to accommodate each incoming nucleotide, and the tRNA remains fixed. This mechanism was demonstrated by Shi et al. using the E. coli enzyme.
Nucleotide selection and catalysis
In simple terms: The enzyme chooses the right nucleotides and links them together.
The enzyme uses ATP and CTP as substrates and releases pyrophosphate. It first adds two CMP residues, then one AMP residue, generating the 3' CCA end. The reaction is driven by nucleotide triphosphate hydrolysis and is independent of a nucleic acid template.
Product release and tRNA maturation
In simple terms: The finished tRNA is released and is ready to carry an amino acid.
After CCA addition, the mature tRNA is released. The 3' CCA end is then recognized by aminoacyl-tRNA synthetases, which attach the correct amino acid. This step is essential for translation.
Alternative substrates and moonlighting functions
In simple terms: The enzyme can also modify other RNAs, not just tRNA.
The CCA-adding enzyme can add CCA to U2 small nuclear RNA, indicating a broader role in RNA processing. This activity was shown for the human enzyme and suggests that GO:0004810 contributes to spliceosomal RNA maturation.
Key Genes Involved in GO:0004810 CCA tRNA nucleotidyltransferase activity
The following genes and proteins are directly associated with CCA tRNA nucleotidyltransferase activity, based on published biochemical and genetic studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| cca (E. coli) | Encodes tRNA nucleotidyltransferase; adds CCA to tRNA | Model enzyme for mechanism and substrate specificity |
| cca (B. subtilis) | Encodes tRNA CCA-adding enzyme | Gram-positive model for tRNA maturation |
| TRNT1 (human) | Encodes tRNA nucleotidyltransferase; adds CCA to tRNA and U2 snRNA | Disease-linked variants cause retinitis pigmentosa and immunodeficiency |
| MenT (M. tuberculosis) | Nucleotidyltransferase toxin that extends tRNA acceptor ends | Toxin-antitoxin system controlling growth |
| U2 snRNA | Substrate for CCA addition by the enzyme | Links CCA activity to spliceosomal RNA processing |
| tRNA precursors | Substrates lacking 3' CCA | Direct readout of enzyme activity |
| ATP | Substrate for AMP addition | Required for CCA synthesis |
| CTP | Substrate for CMP addition | Required for CCA synthesis |
| Aminoacyl-tRNA synthetases | Recognize 3' CCA end | Downstream effectors of CCA addition |
| Ribosomes | Use mature tRNA for translation | Functional output of CCA addition |
| TRNT1 variants | Disease-linked mutations | Altered stability and activity |
| E. coli cca deletion | Viable but with growth defects | Shows non-essentiality under standard conditions |
| B. subtilis cca | Essential for tRNA maturation | Gram-positive model |
| Human TRNT1 | Mitochondrial and cytoplasmic tRNA maturation | Disease relevance |
| MenT toxin | Modifies tRNA to control growth | Antibacterial target |
| U2 snRNA | Alternative substrate | Expands functional repertoire |
How Is CCA tRNA nucleotidyltransferase activity Regulated?
The expression and activity of CCA tRNA nucleotidyltransferase are regulated at multiple levels. In E. coli, the cca gene is constitutively expressed but can be induced under stress conditions. In humans, TRNT1 expression is regulated by cellular demand for tRNA maturation, and disease-linked variants affect protein stability and catalytic activity. The activity can also be modulated by toxin-antitoxin systems, such as MenT in Mycobacterium tuberculosis, which modifies tRNA acceptor ends to control growth.
CCA tRNA nucleotidyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TRNT1 | Retinitis pigmentosa, immunodeficiency, developmental delay | Knockout or point-mutation human cell lines; patient-derived fibroblasts |
| MenT | Tuberculosis growth control | Mycobacterium tuberculosis knockout or overexpression |
| cca (E. coli) | Non-essential for viability but growth defects | E. coli cca deletion strain |
| cca (B. subtilis) | tRNA maturation | B. subtilis cca knockout |
| U2 snRNA | Spliceosomal RNA processing | Human cell lines with TRNT1 knockdown |
TRNT1-related disease
Mutations in human TRNT1 cause a rare autosomal recessive disorder characterized by retinitis pigmentosa, immunodeficiency, and developmental delay. In vitro studies of disease-linked variants show decreased thermal stability and altered catalytic activity, providing a molecular basis for the disease. The condition is part of the nonsyndromic retinitis pigmentosa spectrum.
Bacterial growth control and persistence
In Mycobacterium tuberculosis, the nucleotidyltransferase toxin MenT extends aminoacyl acceptor ends of serine tRNAs to control growth. This toxin-antitoxin system links CCA-related activity to bacterial persistence and represents a potential antibacterial target.
RNA processing and spliceosome
The CCA-adding enzyme can modify U2 small nuclear RNA, suggesting that defects in this activity could impact spliceosomal function. This connection expands the disease relevance of GO:0004810 beyond tRNA.
From CCA tRNA nucleotidyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is TRNT1 essential for human cell viability? | CRISPR knockout of TRNT1 in human cell lines |
| How do disease-linked TRNT1 variants affect enzyme stability? | Point-mutation knock-in of patient variants |
| Does CCA addition occur on U2 snRNA in vivo? | Knock-in of tagged TRNT1 followed by RNA immunoprecipitation |
| Can MenT toxin be targeted for antibacterial therapy? | Mycobacterium tuberculosis MenT knockout or overexpression |
| What is the role of cca in E. coli stress response? | E. coli cca deletion and complementation |
| How does CCA addition affect translation efficiency? | Overexpression of TRNT1 followed by polysome profiling |
How to Study the CCA tRNA nucleotidyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro CCA-adding assay | Enzyme activity and kinetics | Characterizing wild-type and mutant TRNT1 |
| tRNA-seq | tRNA abundance and 3' end status | Assessing tRNA maturation defects |
| RNA immunoprecipitation | Binding of TRNT1 to RNA substrates | Identifying U2 snRNA as a substrate |
| CRISPR knockout screen | Gene essentiality and synthetic lethality | Finding modifiers of TRNT1 loss |
| X-ray crystallography | Three-dimensional structure | Mechanistic studies of CCA addition |
| Polysome profiling | Translation efficiency | Linking CCA addition to protein synthesis |
| Western blot | Protein stability | Assessing TRNT1 variant stability |
| Growth assays | Bacterial viability | Testing MenT toxin effects |
Enzymatic assays
In vitro CCA-adding assays using recombinant enzyme and tRNA precursors measure the incorporation of radiolabeled ATP or CTP. These assays are used to determine kinetic parameters and substrate specificity.
RNA sequencing and modification mapping
RNA-seq and specialized methods such as tRNA-seq can detect the presence or absence of the 3' CCA end on tRNAs. These approaches are used to assess the impact of TRNT1 mutations on tRNA maturation.
Structural biology
X-ray crystallography and cryo-EM have been used to solve structures of CCA-adding enzymes bound to tRNA and nucleotides, revealing the mechanism of template-independent polymerization.
Genetic screens
CRISPR knockout screens in human cells can identify genes that modify the cellular response to TRNT1 loss, revealing synthetic lethal interactions and pathways.
How CRISPR Can Be Used to Study GO:0004810 CCA tRNA nucleotidyltransferase activity
Knockout
CRISPR knockout of TRNT1 in human cell lines can model the loss of CCA-adding activity and reveal cellular consequences such as tRNA maturation defects and reduced translation. Knockout of cca in E. coli is viable but shows growth defects, making it a useful model for studying non-essential functions.
Point Mutation
Point mutations identified in patients with TRNT1-related disease can be introduced into cell lines using CRISPR base editing or homology-directed repair. These models show decreased thermal stability and altered catalytic activity, providing insight into genotype-phenotype relationships.
Knock-in
Knock-in of tagged TRNT1 (e.g., FLAG or GFP) allows for RNA immunoprecipitation and localization studies. This approach can confirm the interaction of TRNT1 with U2 snRNA and other RNA substrates.
Overexpression
Overexpression of TRNT1 or bacterial cca can be used to study the effects of increased CCA-adding activity on tRNA maturation and translation. Overexpression models can also reveal dominant-negative effects of disease variants.
How EDITGENE Supports CCA tRNA nucleotidyltransferase activity Research
Researchers studying CCA tRNA nucleotidyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in tRNA maturation, translation, or disease. EDITGENE provides CRISPR-based cell models and screening services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for CCA tRNA nucleotidyltransferase activity research.
Frequently Asked Questions About CCA tRNA nucleotidyltransferase activity
What is CCA tRNA nucleotidyltransferase activity?
It is the enzymatic activity (GO:0004810) that adds the 3' CCA trinucleotide to tRNA precursors using ATP and CTP, generating mature tRNA ends required for aminoacylation.
What genes are involved in CCA tRNA nucleotidyltransferase activity?
The main genes are cca in E. coli and B. subtilis, and TRNT1 in humans. The MenT toxin in Mycobacterium tuberculosis also has related activity.
What is the reaction catalyzed by CCA tRNA nucleotidyltransferase?
The reaction is: a tRNA precursor + ATP + 2 CTP = a tRNA with a 3' CCA end + 3 diphosphate.
Why is the 3' CCA end important?
The 3' CCA end is the amino acid attachment site of tRNA. Without it, aminoacyl-tRNA synthetases cannot charge tRNA, and protein synthesis is impaired.
Is CCA tRNA nucleotidyltransferase essential for life?
In E. coli, the cca gene is not essential for viability under standard laboratory conditions, but loss causes growth defects. In humans, TRNT1 mutations cause a multisystem disease.
What diseases are linked to TRNT1 mutations?
TRNT1 mutations cause retinitis pigmentosa, immunodeficiency, and developmental delay. Disease-linked variants show decreased thermal stability and altered catalytic activity.
How is CCA addition studied experimentally?
Common methods include in vitro CCA-adding assays, tRNA-seq, RNA immunoprecipitation, and CRISPR knockout screens.
Can the CCA-adding enzyme modify other RNAs?
Yes, the human enzyme can add CCA to U2 small nuclear RNA, suggesting a broader role in RNA processing.
What is the mechanism of CCA addition?
The enzyme adds CTP, CTP, and ATP sequentially without translocating along the tRNA, using a template-independent mechanism.
How can CRISPR help study CCA tRNA nucleotidyltransferase activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to dissect the role of TRNT1 and cca in tRNA maturation and disease.
Conclusion
GO:0004810, CCA tRNA nucleotidyltransferase activity, is a fundamental molecular function that ensures tRNA molecules carry the 3' CCA end required for aminoacylation and translation. Its mechanism of template-independent polymerization has been studied for decades, and its relevance to human disease is underscored by TRNT1 mutations that cause retinitis pigmentosa and immunodeficiency. The activity also plays roles in bacterial growth control and RNA processing, making it a versatile target for research. CRISPR-based models and screening approaches will continue to illuminate its functions and therapeutic potential.
References
- 1. Adam MP et al.. 1993. Nonsyndromic Retinitis Pigmentosa Overview.. PMID: 20301590
- 2. Shi PY et al.. 1998. CCA addition by tRNA nucleotidyltransferase: polymerization without translocation?. EMBO J 17(11):3197-206 PMID: 9606201
- 3. Xu X et al.. 2024. Nucleotidyltransferase toxin MenT extends aminoacyl acceptor ends of serine tRNAs to control Mycobacterium tuberculosis growth.. Nat Commun 15(1):9596 PMID: 39505885
- 4. Raynal LC et al.. 1998. The Bacillus subtilis nucleotidyltransferase is a tRNA CCA-adding enzyme.. J Bacteriol 180(23):6276-82 PMID: 9829937
- 5. Leibovitch M et al.. 2018. In vitro studies of disease-linked variants of human tRNA nucleotidyltransferase reveal decreased thermal stability and altered catalytic activity.. Biochim Biophys Acta Proteins Proteom 1866(4):527-540 PMID: 29454993
- 6. Cudny H et al.. 1986. Cloning, sequencing, and species relatedness of the Escherichia coli cca gene encoding the enzyme tRNA nucleotidyltransferase.. J Biol Chem 261(14):6444-9 PMID: 3009457
- 7. Zhu L et al.. 1987. tRNA nucleotidyltransferase is not essential for Escherichia coli viability.. EMBO J 6(8):2473-7 PMID: 3311729
- 8. Cho HD et al.. 2002. U2 small nuclear RNA is a substrate for the CCA-adding enzyme (tRNA nucleotidyltransferase).. J Biol Chem 277(5):3447-55 PMID: 11700323
